GF Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

GF Fund Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,714	Closed	-$358K	–	701
2025 Q1	$358K	Buy	2,714 +488	+22%	+$60.8K	0.01%	280
2024 Q4	$186K	Buy	+2,226	New	+$183K	﹤0.01%	297

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GF Fund Management's ITCI Position: Q2 2025 in Review

GF Fund Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,714 shares — an estimated $358K sold.

GF Fund Management first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $358K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

GF Fund Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
GF Fund Management sold 2,714 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $358K.
GF Fund Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
GF Fund Management's Intra-Cellular Therapies Inc. position peaked at $358K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.